Home > Insider Trading > Filing (0001144204-15-055967)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1541157	Akari Therapeutics Plc	AKTX	Pharmaceutical Preparations (2834)	981034922

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622779	S Mark Cohen	C/O Akari Therapeutics Plc 24 West 40Th Street, 8Th Floor New York NY 10018		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-09-18	1,055,600	$0.19	1,055,600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Options to Purchase Ordinary Shares	Acquisiton	2015-09-21	85,000	$0.00	85,000	$0.32
Ordinary Shares	Options to Purchase Ordinary Shares	Acquisiton	2015-09-21	186,278	$0.00	186,278	$0.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
85,000	2016-09-21	2025-09-21	No	4	A	Direct
186,278	2016-09-21	2025-09-21	No	4	A	Direct

Footnotes

The Company's American Depository Shares ("ADSs"), which began trading on The NASDAQ Capital Market under the symbol "AKTX" commencing on September 21, 2015, each represent 100 Ordinary Shares (giving effect to a previously announced ADS ratio change). The non-derivative and derivative equity securities described herein are listed in terms of Ordinary Shares rather than ADSs.
All shares underlying the options will vest on September 21, 2016 and expire 10 years from issuance.